Cytogenetic and clinical characteristics of t(7;12) patients
(A) Percentage of t(7;12) patient cases where a MNX1/ETV6 transcript was detected. (B) Distribution of age at diagnosis of t(7;12) patients. (C) Proportion of additional numerical cytogenetic abnormalities in conjunction with t(7;12). (D) Percentage of French American British (FAB) categories of t(7;12) at diagnosis. NOS = not otherwise specified. (E) Contingency table of co-occurrence of clinical features of t(7;12) patients showing the odds ratio and statistical significance as P-value (threshold < 0.05) obtained by Fisher’s exact test. (F) Proportion of t(7;12) patients divided by age (older than 8 months vs younger than 8 months) and the FAB subtype at diagnosis (undifferentiated M0-M2 vs differentiated M3-M7). Statistical significance was calculated by Fisher’s exact test.